Skip to main content
. 2001 Feb;10(2):277–284. doi: 10.1110/ps.26401

Fig. 5.

Fig. 5.

UEA-II does not alter serum hemolytic activity. Complement hemolytic assays using sensitized chicken red blood cells were performed in order to demonstrate that UEA-II does not directly inhibit or activate complement. Treatment of HS with UEA-II (1 μmol/L) did not significantly alter hemolytic activity compared to untreated HS. (n = 2, error bars = SEM.)